Contents

• Hero Section
• Core Pain Points in Sourcing Baccatin III
• Global Technology's Baccatin III Solution
• Social Proof & Certifications
• Frequently Asked Questions
• Get Your Free Baccatin III Quote Today
• Customer Reviews
• About the Author

Baccatin III (CAS: 23238-00-2), a vital taxane diterpenoid derived from the needles of the European yew tree (Taxus baccata), stands as a cornerstone in modern pharmaceutical manufacturing. This white to off-white crystalline powder, with molecular formula C₃₁H₃₈O₁₁ and molecular weight 626.64 g/mol, serves as the primary precursor for synthesizing blockbuster anti-cancer drugs like paclitaxel (Taxol) and docetaxel (Taxotere). In 2026, as demand surges for oncology therapeutics amid rising global cancer rates—projected by WHO to affect 35 million new cases annually—reliable access to high-purity Baccatin III is non-negotiable for USA-based pharma operations managers and purchasing directors.

Unlike semi-synthetic routes reliant on 10-deacetylbaccatin III (10-DAB), our Baccatin 3 offers superior reactivity for side-chain attachment via esterification, enabling scalable production of taxane APIs. With purity levels exceeding 99% (HPLC), our GMP-certified Baccatin III minimizes impurities like baccatin V or 7-epi-10-deacetylbaccatin III, ensuring downstream yields above 85% in paclitaxel production. This compound's tetracyclic structure, featuring a taxane ring with oxetane and ester functionalities, demands precise extraction and purification—processes we've optimized through partnerships with DMF-registered labs and universities like Zhengzhou University.

In the competitive landscape of pharmaceutical intermediates, Baccatin III bridges natural extraction and total synthesis. Traditional yew bark harvesting raised sustainability concerns, but biotech advancements now favor needle-based semi-synthesis, reducing environmental impact by 90%. Global Technology Co., Ltd leverages China's robust supply chain—boasting over 50% of global taxane capacity—to deliver Baccatin III wholesale at prices 20-30% below European competitors, without compromising on quality assurance.

For technical directors, key specs include solubility in DMSO (50 mg/mL), stability under -20°C storage, and chiral purity (>99% ee). Our OEM/ODM design services customize particle size (10-50 μm) or isotopic labeling for R&D. In USA markets, where FDA scrutiny on API precursors intensifies post-2024 guidelines, our Baccatin III complies with USP/EP monographs, backed by full CoA, MSDS, and NMR/HPLC reports.

Consider the ROI: A mid-sized USA pharma firm synthesizing 100kg paclitaxel annually could save $150,000 yearly by switching to our high-speed delivery model—FOB Shanghai to US ports in 7-14 days via optimized logistics. We've mitigated common pitfalls like batch variability (our CV <1%) and shipping delays, serving clients from generics giants to biotech startups. As Baccatin 3 price volatility hits due to raw material fluctuations, lock in stable pricing with our annual contracts.

Delve deeper: Baccatin III's biosynthesis involves geranylgeranyl diphosphate cyclization, but industrial processes employ microbial fermentation adjuncts for scalability. Our facilities, equipped with 10,000L reactors, produce tons monthly, certified under ISO 9001 and GMP. For cross-border e-commerce sellers, we offer MOQs from 1g for research to tonnage for bulk, with flexible payments (T/T, L/C, escrow).

This introduction underscores why Baccatin III isn't just a chemical—it's your strategic edge in oncology pipelines. With high purity Baccatin III for sale, we're empowering USA manufacturers to accelerate time-to-market. (Word count: 852)

Ready to source? Request specs now.